Screener
Viridian Therapeutics, Inc. VRDN Business Segments — Other items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | 2025 |
|---|---|---|---|---|
| Segment research and development expense (a) | $64,189 | $81,401 | $135,933 | $152,439 |
| Segment selling, general and administrative expense (a) | 45,262 | 14,483 | 76,317 | 27,047 |
| Share-based compensation expense (see Note 11) | 16,984 | 10,844 | 30,374 | 21,064 |
| Total operating expenses, excluding depreciation expense | 126,435 | 106,728 | 242,624 | 200,550 |
| License revenue | 180 | — | 186 | — |
| Other items (b) | 504 | (5,993) | (10,790) | (12,903) |
| Consolidated net loss | $127,119 | $100,735 | $232,020 | $187,647 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s business segments — other items?
- Viridian Therapeutics, Inc. (VRDN) reported business segments — other items of $504K in Q2 2026.
- How has Viridian Therapeutics, Inc.'s business segments — other items changed year-over-year?
- Viridian Therapeutics, Inc.'s business segments — other items increased by 108.4% year-over-year, from -$5.99M to $504K.
- What is the long-term trend for Viridian Therapeutics, Inc.'s business segments — other items?
- Over 3 years (2022 to 2025), Viridian Therapeutics, Inc.'s business segments — other items has grown at a 50.6% compound annual growth rate (CAGR), from -$6.2M to -$21.18M.
- What does business segments — other items mean?
- This metric captures miscellaneous income or expense items that do not fall under core research, development, or administrative categories within the business segment. It often includes non-recurring or peripheral financial activities that impact the segment's bottom line. Tracking these items helps isolate core operational performance from incidental financial events.
Ask your AI about Viridian Therapeutics, Inc.'s business segments — other items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude